NIH-funded research R37 grant

Understanding how ions affect glutamate transport in the brain

Official title: Ion coupling, permeation, and regulation in glutamate transporters

Funded at Weill Medical Coll of Cornell Univ · NIH-11003751 · Data updated 2026-11-12

This study is looking at how certain particles in the brain help transport a key chemical called glutamate, which is important for memory and learning, and it aims to understand how this process works in both healthy brains and those with neurological issues.

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startJanuary 1, 2024
Project endDecember 31, 2027
Funding year2025
Award (this year)$523,047
NIH project number5R37NS134865-02
Project IDNIH-11003751 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with neurological disorders that involve glutamate dysregulation, such as epilepsy, Alzheimer's disease, or multiple sclerosis.

Less likely to help

Patients with conditions unrelated to glutamate transport or those who do not have neurological disorders may not benefit from this research.

What this research studies

This research investigates the role of ions in the function of glutamate transporters, which are crucial for neurotransmission in the brain. By examining how these transporters operate under both healthy and diseased conditions, the research aims to uncover the mechanisms that regulate glutamate levels, which are vital for cognitive functions like memory and learning. The study employs advanced techniques such as cryo-electron microscopy and single-molecule fluorescence microscopy to analyze the transporters at a molecular level. This comprehensive approach will help identify how ion interactions influence transporter behavior and their implications for neurological disorders.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for neurological disorders linked to glutamate dysregulation.

How similar studies have gone: Previous research has shown promising results in understanding neurotransmitter transport mechanisms, indicating that this approach has the potential for significant insights.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Boudker, Olga — Weill Medical Coll of Cornell Univ
  • Study coordinator: Boudker, Olga

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.